캐나다 - 영어 - Health Canada

organon canada inc. - lipase; amylase; protease - capsule (delayed release) - 10800unit; 42000unit; 45000unit - lipase 10800unit; amylase 42000unit; protease 45000unit - digestants

캐나다 - 영어 - Health Canada

organon canada inc. - lipase; amylase; protease - capsule (delayed release) - 25000unit; 100000unit; 100000unit - lipase 25000unit; amylase 100000unit; protease 100000unit - digestants

캐나다 - 영어 - Health Canada

vivus llc. - lipase; amylase; protease - capsule (delayed release) - 16800unit; 70000unit; 40000unit - lipase 16800unit; amylase 70000unit; protease 40000unit - digestants

캐나다 - 영어 - Health Canada

vivus llc. - lipase; amylase; protease - capsule (delayed release) - 4200unit; 17500unit; 10000unit - lipase 4200unit; amylase 17500unit; protease 10000unit - digestants

캐나다 - 영어 - Health Canada

vivus llc. - lipase; amylase; protease - capsule (delayed release) - 2600unit; 10850unit; 6200unit - lipase 2600unit; amylase 10850unit; protease 6200unit - digestants

캐나다 - 영어 - Health Canada

vivus llc. - lipase; amylase; protease - capsule (delayed release) - 21000unit; 61000unit; 37000unit - lipase 21000unit; amylase 61000unit; protease 37000unit - digestants

캐나다 - 영어 - Health Canada

trophic canada ltd. - vitamin a; vitamin e; ascorbic acid; wheat germ oil; rose hips; phosphatidyl choline; lipase - tablet - 10000unit; 100unit; 100mg; 50mg; 10mg; 10mg; 10mg - vitamin a 10000unit; vitamin e 100unit; ascorbic acid 100mg; wheat germ oil 50mg; rose hips 10mg; phosphatidyl choline 10mg; lipase 10mg - multivitamin preparations

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - amylase 30000 usp u (component of pancrelipase); pancrelipase 275mg; protease 30000 usp u (component of pancrelipase); rizolipase 8000 usp u (component of pancrelipase) - capsule - 8k/30k/30kusp u - active: amylase 30000 usp u (component of pancrelipase) pancrelipase 275mg protease 30000 usp u (component of pancrelipase) rizolipase 8000 usp u (component of pancrelipase) excipient: cellacefate colloidal silicon dioxide diethyl phthalate gelatin hydrated silica maize starch opacode povidone propylene glycol propylene glycol monostearate purified talc sodium laurilsulfate sucrose

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 300mg (amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u.); pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u; pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u - modified release capsule - 300 mg - active: pancreatin 300mg (amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u.) excipient: acetone dibutyl phthalate dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow liquid paraffin macrogol 4000 propyl alcohol titanium dioxide active: pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate active: pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

viatris limited - pancreatin 150mg (amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u.); pancreatin 150mg equivalent to amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u. - modified release capsule - 150 mg - active: pancreatin 150mg (amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u.) excipient: acetone dibutyl phthalate dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow liquid paraffin macrogol 4000 propyl alcohol titanium dioxide active: pancreatin 150mg equivalent to amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u. excipient: cetyl alcohol dimeticone ferrosoferric oxide gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).